Merck and Moderna say cancer vaccine shows promise in preventing recurrence of melanoma
1 week ago
33
ARTICLE AD BOX
Pharmaceutical giants Moderna and Merck said that an experimental vaccine treatment has shown signs of preventing skin cancer from returning or spreading in a study of melanoma patients.